Quest Diagnostics Inc Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Quest Diagnostics Inc (DGX) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $2.00 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-04-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2016-10-21
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2016-03-31 was $2.00M, a 33.33% decline year-over-year.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-09-30 was $1.00M.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-06-30 was $0.00.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-03-31 was $3.00M.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was -$3.00M, a 400.00% decline from fiscal 2013.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $1.00M, a 88.89% decline from fiscal 2012.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2012 was $9.00M, a 12.50% increase from fiscal 2011.
- Quest Diagnostics Inc adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $8.00M, a 106.19% increase from fiscal 2010.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2016-03-31 | $2.00M 10-Q · filed 2016-04-27 | ||||||
| 2015-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | $1.00M derived: sum of 2 quarters · filed 2016-10-21 | $4.00M 10-Q · filed 2016-10-21 | $2.00M derived: sum of 4 quarters · filed 2016-10-21 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-25 | $3.00M 10-Q · filed 2016-07-25 | $1.00M derived: sum of 3 quarters · filed 2016-07-25 | ||||
| 2015-03-31 | $3.00M 10-Q · filed 2016-04-27 | $1.00M derived: sum of 2 quarters · filed 2016-04-27 | |||||
| 2014-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$3.00M 10-K · filed 2015-02-24 | |||||
| 2014-09-30 | -$1.00M 10-Q · filed 2015-10-29 | ||||||
| 2014-03-31 | -$2.00M 10-Q · filed 2015-04-30 | $0.00 derived: sum of 2 quarters · filed 2015-04-30 | -$610.00K derived: sum of 3 quarters · filed 2015-04-30 | $0.00 derived: sum of 4 quarters · filed 2015-04-30 | |||
| 2013-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.39M derived: sum of 2 quarters · filed 2015-02-24 | $2.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.00M 10-K · filed 2015-02-24 | |||
| 2013-09-30 | -$610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 derived: sum of 2 quarters · filed 2014-10-30 | -$1.00M 10-Q · filed 2014-10-30 | -$906.00K 10-Q · filed 2013-10-24 | $3.15M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$390.00K 10-Q · filed 2013-07-25 | $3.77M derived: sum of 3 quarters · filed 2015-02-24 | $3.83M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | -$1.00M 10-Q · filed 2014-05-01 | -$555.00K 10-Q · filed 2013-04-24 | $3.15M derived: sum of 2 quarters · filed 2015-02-24 | $3.22M derived: sum of 3 quarters · filed 2015-02-24 | $3.58M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $4.22M derived: sum of 2 quarters · filed 2015-02-24 | $4.58M derived: sum of 3 quarters · filed 2015-02-24 | $9.00M 10-K · filed 2015-02-24 | $8.51M 10-K · filed 2013-02-27 | ||
| 2012-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $420.00K derived: sum of 2 quarters · filed 2013-10-24 | $4.84M 10-Q · filed 2013-10-24 | $6.43M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2012-06-30 | $355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $4.78M 10-Q · filed 2013-07-25 | $6.36M derived: sum of 3 quarters · filed 2014-02-18 | $6.32M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2012-03-31 | $4.42M 10-Q · filed 2013-04-24 | $6.01M derived: sum of 2 quarters · filed 2014-02-18 | $5.96M derived: sum of 3 quarters · filed 2014-02-18 | $6.66M derived: sum of 4 quarters · filed 2014-02-18 | |||
| 2011-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $1.54M derived: sum of 2 quarters · filed 2014-02-18 | $2.23M derived: sum of 3 quarters · filed 2014-02-18 | $8.00M 10-K · filed 2014-02-18 | $7.96M 10-K · filed 2012-02-16 | ||
| 2011-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $654.00K derived: sum of 2 quarters · filed 2012-10-24 | $6.42M 10-Q · filed 2012-10-24 | $7.62M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-30 | $699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $6.46M 10-Q · filed 2012-07-26 | $7.67M derived: sum of 3 quarters · filed 2013-02-27 | $7.72M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-31 | $5.76M 10-Q · filed 2012-04-27 | $6.97M derived: sum of 2 quarters · filed 2013-02-27 | $7.02M derived: sum of 3 quarters · filed 2013-02-27 | $7.77M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.25M derived: sum of 2 quarters · filed 2013-02-27 | $2.00M derived: sum of 3 quarters · filed 2013-02-27 | $3.88M 10-K · filed 2013-02-27 | |||
| 2010-09-30 | $47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $800.00K derived: sum of 2 quarters · filed 2011-11-03 | $2.67M 10-Q · filed 2011-11-03 | $5.91M derived: sum of 4 quarters · filed 2012-02-16 | |||
| 2010-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $2.63M 10-Q · filed 2011-07-27 | $5.86M derived: sum of 3 quarters · filed 2012-02-16 | $8.09M derived: sum of 4 quarters · filed 2012-02-16 | |||
| 2010-03-31 | $1.88M 10-Q · filed 2011-05-10 | $5.11M derived: sum of 2 quarters · filed 2012-02-16 | $7.34M derived: sum of 3 quarters · filed 2012-02-16 | ||||
| 2009-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $5.46M derived: sum of 2 quarters · filed 2012-02-16 | $6.85M 10-K · filed 2012-02-16 | ||||
| 2009-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $3.61M 10-Q · filed 2010-10-26 | |||||
| 2009-06-30 | $1.38M 10-Q · filed 2010-07-27 | ||||||
| 2008-12-31 | $6.88M 10-K · filed 2011-02-16 | ||||||
| 2007-12-31 | $16.70M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |